NPPA fixed retail price of 33 formulations: November 2023

Last Updated on December 31, 2023 by The Health Master

Download NPPA notification No. S.O. 4885 (E) dt 10-11-2023, the link is given below: The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of 33 formulations under the Drugs (Prices Control) Order, 2013, vide S.O. 4885(E) dt 10-11-2023.

The notification states as follows:

In exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S. O. 5249(E) dated 11th November, 2022 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA), hereby fixes, the price as specified in column (6) of the table herein below as the retail price, exclusive of Goods and Services Tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer & marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof;

A table is given below the article

Note:
(a) The manufacturer of the above-mentioned formulations, i.e., the “new drug” under paragraph 2(1)(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove.

(b) The manufacturer may add Goods and Services Tax only if they have actually paid it or it is payable to the Government on the retail price mentioned in column (6) of the above-mentioned table.

(c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013.

The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.

(d) As per para 24(4) of DPCO 2013, every retailer and dealer shall display the price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.

(e) The above mentioned retail price is applicable only to the individual manufacturer / marketer as mentioned above, i.e., those who have applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to the fulfillment of all the applicable statutory requirements as laid down by the government under relevant statutes or rules,
including manufacturing license permission from the competent authority, i.e., the central or state licensing authority, as may be applicable, by the concerned manufacturer/marketing company.

(f) In case the retail price of any of the aforesaid formulations is not complied with, as per the instant price notification and notes specified hereinabove, then the concerned manufacturer / marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.

(g) Consequent to the fixation of retail price of such formulation as specified in column (2) of the above table with the strength and name of the manufacturer and marketing company specified in the corresponding entries in Column (3) & (5) thereof, the price order(s) fixing the retail price of the formulation with specified strength for that Manufacturer and marketing company
Companies as specified in corresponding entries in Columns (2), (3), and (5) thereof, if any, issued prior to this notification, stand superseded.

Table

Sl. No.	Name of the Formulation / Brand Name	Strength	Unit	Manufacturer & Marketing Company	Retail Price (Rs.)
(1)	(2)	(3)	(4)	(5)	(6)
1	Metoprolol Succinate Extended Release, Cilnidipine & Telmisartan Tablet	Each film coated bilayered tablet contains: Metoprolol Succinate IP 23.75mg eq. to Metoprolol Tartrate 25mg (As Extended release) Telmisartan IP 40mg, Cilnidipine IP 10mg	1 Tablet	M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Unison Pharmaceuticals Pvt. Ltd.	10.04
2	Amoxycillin + Potassium Clavulanate Oral Suspension	Each combi pack contains: Amoxycillin and Potassium Clavulanate Oral Suspension IP Each 5ml of Reconstituted suspension contains: Amoxycillin Trihydrate IP eq. to Amoxycillin 400mg Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 57mg Sterile water for Reconsitution-30 ml	1 ml	M/s Malik Life Sciences Pvt. Ltd. / M/s Blue Cross Laboratories Pvt. Ltd.	4.16
3	Vildagliptin + Metformin Hydrochloride Tablet	Each film coated tablet contains: Vildagliptin IP 50mg Metformin Hydrochloride IP 1000mg	1 Tablet	M/s Skymap Pharmaceuticals Pvt. Ltd. / M/s Glensmith Labs Pvt. Ltd.	8.32
4	Vildagliptin + Metformin Hydrochloride Tablet	Each film coated tablet contains: Vildagliptin IP 50mg Metformin Hydrochloride IP 500mg	1 Tablet	M/s Skymap Pharmaceuticals Pvt. Ltd. / M/s Glensmith Labs Pvt. Ltd.	7.89
5	Telmisartan and Bisoprolol Fumarate Tablets	Each film coated tablet contains: Telmisartan IP 40mg Bisoprolol Fumarate IP 2.5mg	1 Tablet	M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Unison Pharmaceuticals Pvt. Ltd.	9.62
6	Telmisartan and Bisoprolol Fumarate Tablets	Each film coated tablet contains: Telmisartan IP 40mg Bisoprolol Fumarate IP 5mg	1 Tablet	M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Unison Pharmaceuticals Pvt. Ltd.	11.31
7	Metoprolol Succinate Extended Release, Cilnidipine & Telmisartan Tablet	Each film coated bilayered tablet contains: Metoprolol Succinate IP 47.50mg eq. to Metoprolol Tartrate 50mg (As Extended release) Telmisartan IP 40mg, Cilnidipine IP 10mg	1 Tablet	M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Unison Pharmaceuticals Pvt. Ltd.	12.46
8	Atorvastatin & Ezetimibe Tablets	Each film coated tablet contains: Atorvastatin Calcium IP eq. to Atorvastatin 20mg Ezetimibe IP 10mg	1 Tablet	M/s Mascot Health Series Pvt. Ltd. / M/s Eris Lifesciences Limited	23.85
9	Atorvastatin & Ezetimibe Tablets	Each film coated tablet contains: Atorvastatin Calcium IP eq. to Atorvastatin 40mg Ezetimibe IP 10mg	1 Tablet	M/s Mascot Health Series Pvt. Ltd. / M/s Eris Lifesciences Limited	32.61
10	Cholecalciferol (Vitamin D3) Oral Solution 60000IU	Each 5ml Syrup contains: Cholecalciferol 60000 IU	1 ml	M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Zuventus Healthcare Limited	12.27

11	Telmisartan and Metoprolol Succinate (ER) Tablet	Each film coated bilayered tablet contains: Telmisartan IP 40mg Metoprolol Succinate IP 23.75mg eq. to Metoprolol Tartrate 25mg (as extended- release form)	1 Tablet	M/s Pure and Cure Healthcare Pvt. Ltd. / M/s La Renon Healthcare Pvt. Ltd.	11.96
12	Ceftriaxone & Sulbactam for Injection	Each vial contains: Sterile Ceftriaxone Sodium IP eq. to Ceftriaxone 1000mg Sterile Sulbactam Sodium IP eq. to Sulbactam 500mg	1 vial	M/s Scott-Edil Advance Research Laboratories and Eduction Ltd. / M/s J.B. Chemicals & Pharmaceuticals Ltd.	142.48
13	Bisoprolol Fumarate & Amlodipine tablet	Each film coated tablet contains: Bisoprolol Fumarate IP 2.5mg Amlodipine Besylate IP Eq. to Amlodipine 5mg	1 Tablet	M/s Unison Pharmaceuticals Pvt. Ltd.	6.19
14	Bisoprolol Fumarate & Amlodipine tablet	Each film coated tablet contains: Bisoprolol Fumarate IP 5mg Amlodipine Besylate IP Eq. to Amlodipine 5mg	1 Tablet	M/s Unison Pharmaceuticals Pvt. Ltd.	8.34
15	Amoxycillin & Potassium Clavulanate Oral Suspension IP	Each 5ml (after reconstitution) contains: Amoxycillin Trihydrate IP eq. to Amoxycillin 400mg Potassium Clavulanate diluted IP eq. to Clavulanic Acid 57mg	1 ml	M/s Uni Medico Labs / M/s Torrent Pharmaceuticals Ltd.	4.20
16	Diclofenac Diethylamine, Methyl Salicylate, Menthol & Virgin Linseed Oil Topical Spray	Composition: Diclofenac Diethylamine IP 1.16%w/w eq. to Diclofenac Sodium IP 1% w/w Virgin Linseed Oil BP 3% w/w Methyl Salicylate IP 10% w/w Menthol IP 5%w/w	1 Gram	M/s Pontika Aerotech Limited / M/s Blue Cross Laboratories Pvt. Ltd.	2.83
17	Rabeprazole Sodium and Domperidone SR Capsules	Each hard gelatin capsule contains: Rabeprazole Sodium IP 20mg (As enteric coated pellets) Domperidone IP 30mg (as Sustained release pellets)	1 Capsule	M/s Aagya Biotech Pvt. Ltd. / M/s German Remedies Pharmaceuticals Pvt. Ltd.	11.52
18	Metronidazole, Lignocaine Hydrochloride and Chlorhexidine Gluconate Gel	Contains: Metronidazole Benzoate IP Metronidazole 1 % w/w Lignocaine Hydrochloride IP 2% w/w Chlorhexidine Gluconate Solution Chlorhexidine Gluconate 1% w/w	1 Gram	M/s J.B. Chemicals & Pharmaceuticals Ltd.	4.22
19	Rosuvastatin + Clopidogrel Capsules	Each hard gelatin capsule contains: Rosuvastatin Calcium IP eq. to Rosuvastatin 20mg (As Pellets) Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg (As Pellets)	1 Capsule	M/s Skymap Pharmaceuticals Pvt. Ltd. / M/s Glensmith Labs Pvt. Ltd.	19.21
20	Rosuvastatin + Clopidogrel Capsules	Each hard gelatin capsule contains: Rosuvastatin Calcium IP eq. to Rosuvastatin 20mg (As Pellets) Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg (As Pellets)	1 Capsule	M/s Skymap Pharmaceuticals Pvt. Ltd.	19.21

21	Rosuvastatin + Clopidogrel Capsules	Each hard gelatin capsule contains: Rosuvastatin Calcium IP eq. to Rosuvastatin 20mg (As Pellets) Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg (As Pellets)	1 Capsule	M/s Skymap Pharmaceuticals Pvt. Ltd. / M/s Jagsonpal Pharmaceuticals Ltd.	19.21
22	Telmisartan and Bisoprolol Fumarate Tablets	Each film coated tablet contains: Telmisartan IP 40mg Bisoprolol Fumarate IP 5mg	1 Tablet	M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Zydus Healthcare Ltd.	11.36
23	Telmisartan and Bisoprolol Fumarate Tablets	Each film coated tablet contains: Telmisartan IP 40mg Bisoprolol Fumarate IP 2.5mg	1 Tablet	M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Zydus Healthcare Ltd.	9.69
24	Hydroxychloroq uine Sulphate tablet	Each film coated tabley contains: Hydroxychloroquine Sulphate IP 300mg	1 Tablet	M/s Innova Captab Ltd. / M/s Brinton Pharmaceuticals Limited	13.54
25	Ibuprofen Injection	Each ml contains: Ibuprofen IP 100mg	1 ml	M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Cipla Ltd.	26.78
26	Paracetamol, Phenylephrine Hydrochloride, Chlorphenirami ne maleate, Ammonium Chloride, Sodium Citrate & Menthol Suspenssion	Each 5ml contains: Paracetamol IP 250mg Phenylephrine Hydrochloride IP 5mg Chlorpheniramine maleate IP 2mg Ammonium Chloride IP 120mg Sodium Citrate IP 60mg Menthol IP 1mg	1 ml	M/s Windlas Biotech Limited / M/s Intas Pharmaceuticals Ltd.	0.82
27	Sitagliptin Phosphate, Metformin Hydrochloride and Glimepiride Tablets	Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride IP 1000mg Glimepiride IP 1 mg	1 Tablet	M/s Sun Pharma Laboratories Limited	13.10
28	Sitagliptin Phosphate, Metformin Hydrochloride and Glimepiride Tablets	Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride IP 1000mg Glimepiride IP 2 mg	1 Tablet	M/s Sun Pharma Laboratories Limited	14.60
29	Linagliptin + Metformin Hydrochloride (ER) Tablet	Each film coated bilayer tablet contains: Linagliptin 5mg Metformin Hydrochloride (as Extended release) IP 1000mg	1 Tablet	M/s Exemed Pharmaceuticals / M/s Emcure Pharmaceuticals Limited	14.37
30	Budesonide, Glycopyrronium and Formoterol Fumarate Dihydrate Inhaler	Each actuation delivers: Budesonide IP 200mcg Glycopyrronium (as Glycopyrrolate IP) 12.5mcg Formoterol Fumarate Dihydrate suspended in propellant IP 6mcg	Per pack of 120 MDI	M/s Cipla Limited	855.00

31	Insulin Glargine 100IU /ml and Lixisenatide 50mcg/ml	Each Prefilled pen containing: Fixed Ratio combination of Insulin Glargine 100IU /ml Lixisenatide 50mcg/ml	1ml	M/s Sanofi Healthcare India Pvt. Ltd. / M/s Sanofi India Limited	587.30
32	Insulin Glargine 100IU /ml and Lixisenatide 33mcg/m	Each Prefilled pen containing: Fixed Ratio combination of Insulin Glargine 100IU /ml Lixisenatide 33mcg/ml	1ml	M/s Sanofi Healthcare India Pvt. Ltd. / M/s Sanofi India Limited	587.30
33	Combikit of Atazanavir + Ritonavir & Emtricitabine + Tenofovir Alafenamide Tablet	Each Combi kit contains: Part A: Each film coated tablet contains: Atazanavir Sulphate IP eq. to Atazanavir 300mg Ritonavir IP 100mg Part B: Each film coated tablet contains: Emtricitabine IP 200mg Tenofovir Alafenamide Fumarate eq. to Tenofovir Alafenamide 10mg	1 Combi kit	M/s Emcure Pharmaceuticals Limited	112.60

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

For informative videos by The Health Master, click on the below YouTube icon:

• Bulk drug import from China continues to rise in 5 years
  December 25, 2024
• Stay action against Pharma units manufacturing Nutraceuticals: High Court
  December 25, 2024
• NPPA fixed retail price of 7 formulations: December 2024
  December 24, 2024
• Revised Schedule M: Industry seeks balance between Quality and Viability
  December 24, 2024
• FDA Karnataka enters a New Era of Food and Drug Safety
  December 24, 2024
• Key Notes on Revised Schedule M: Point No. 13 – Equipment
  December 24, 2024

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

For informative videos on consumer awareness, click on the below YouTube icon: